NHD Global
Incretin receptor agonists are among the most actively studied peptide classes in metabolic research. This group covers single, dual and triple receptor agonists alongside the amylin analogues and lipolytic sequences frequently used with them.
Catalog materials are presented for research use. Analytical methods and lot-document availability vary by material and must be confirmed from the applicable specification and records.
Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 1–6 of 16 reviewed articles · Page 1 of 3
AICAR naming often collapses acadesine, its intracellular phosphorylated metabolite ZMP and an entire AMPK pathway into one label. Reproducible research needs those…
Read source review →A 2024 study reported prevention and reversal of neuropathy measures after experimental AICAR exposure in mouse models of type 1 and type…
Read source review →AOD-9604 is a modified growth-hormone fragment developed around a lipolysis hypothesis. Preclinical plausibility and early development do not override the larger null…
Read source review →AOD-9604 progressed beyond animal work into an obesity-development program. FDA’s 2024 review records that the large OPTIONS study did not show statistically…
Read source review →“Human” in a MOTS-c catalog title ordinarily describes the referenced peptide sequence; it does not mean the material was isolated from a…
Read source review →The paper that introduced MOTS-c combined cell experiments with mouse metabolic models. It is an important discovery record, but the intervention findings…
Read source review →If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.
